Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells

Published on Jul 1, 2016in Gastroenterology19.233
· DOI :10.1053/j.gastro.2016.03.003
Katharina Timper12
Estimated H-index: 12
(University of Basel),
Elise Dalmas8
Estimated H-index: 8
(University of Basel)
+ 9 AuthorsMarc Y. Donath60
Estimated H-index: 60
(University of Basel)
Background & Aims Glucose-dependent insulinotropic peptide (GIP) induces production of interleukin 6 (IL6) by adipocytes. IL6 increases production of glucagon-like peptide (GLP)-1 by L cells and α cells, leading to secretion of insulin from β cells. We investigated whether GIP regulates GLP1 and glycemia via IL6. Methods We obtained samples of human pancreatic islets and isolated islets from mice; human α cells and β cells were sorted by flow cytometry and incubated with GIP. Islets were analyzed by quantitative polymerase chain reaction and immunohistochemistry. BKS.Cg-Dock7m+/+ Leprdb/J db/db mice (diabetic mice) and db/+ mice, as well as C57BL/6J IL6-knockout mice (IL6-KO) and C57BL/6J mice with the full-length Il6 gene (controls), were fed a chow or a high-fat diet; some mice were given injections of recombinant GIP, IL6, GLP, a neutralizing antibody against IL6 (anti-IL6), lipopolysaccharide, and/or IL1B. Mice were given a glucose challenge and blood samples were collected and analyzed. Results Incubation of mouse and human pancreatic α cells with GIP induced their production of IL6, leading to production of GLP1 and insulin secretion from pancreatic islets. This did not occur in islets from IL6-KO mice or in islets incubated with anti-IL6. Incubation of islets with IL1B resulted in IL6 production but directly reduced GLP1 production. Incubation of mouse islets with the sodium glucose transporter 2 inhibitor dapagliflozin induced production of GLP1 and IL6. Injection of control mice with GIP increased plasma levels of GLP1, insulin, and glucose tolerance; these effects were amplified in mice given lipopolysaccharide but reduced in IL6-KO mice or in mice given anti-IL6. Islets from diabetic mice had increased levels of IL1B and IL6, compared with db /+ mice, but injection of GIP did not lead to production of GLP1 or reduce glycemia. Conclusions In studies of pancreatic islets from human beings and mice, we found that GIP induces production of IL6 by α cells, leading to islet production of GLP1 and insulin. This process is regulated by inflammation, via IL1B, and by sodium glucose transporter 2. In diabetic mice, increased islet levels of IL6 and IL1B might increase or reduce the production of GLP1 and affect glycemia.
  • References (44)
  • Citations (30)
📖 Papers frequently viewed together
458 Citations
172 Citations
109 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Berit Svendsen (UCPH: University of Copenhagen)H-Index: 16
#2Jens J. Holst (UCPH: University of Copenhagen)H-Index: 152
Abstract The incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are secreted from enteroendocrine cells in the intestine along with other gut hormones (PYY, CCK and neurotensin) shown to affect metabolism and/or appetite. The secretion of many gut hormones is highly increased after gastric bypass operations, which have turned out to be an effective therapy of not only obesity but also type 2 diabetes. These effects are likely to be due, at le...
23 CitationsSource
#1Katharina Timper (University Hospital of Basel)H-Index: 12
#2Eleonora Seelig (University Hospital of Basel)H-Index: 5
Last. Marc Y. Donath (University Hospital of Basel)H-Index: 60
view all 4 authors...
Abstract Aims The role of the IL-1 system in development of type 2 diabetes is well established. Using an IL-1 receptor antagonist, which blocks IL-1alpha and -beta activity, or by specifically neutralizing IL-1beta, several clinical studies have demonstrated improvement in insulin secretion and glycaemia. However, the role of IL-1alpha remains to be investigated. Methods We evaluated the safety and preliminary efficacy of a neutralizing true human™ monoclonal antibody against IL-1alpha (MABp1) ...
12 CitationsSource
#1Siri Malmgren (Lund University)H-Index: 9
#2Bo Ahrén (Lund University)H-Index: 88
Aims/hypothesis Glucose-lowering therapy with dipeptidyl peptidase-4 (DPP-4) inhibitors is associated with a low risk of hypoglycaemia. We hypothesise that DPP-4 inhibition prevents hypoglycaemia via increased glucagon counterregulation through the incretin hormone glucose-dependent insulinotropic polypeptide (GIP).
26 CitationsSource
#1Caroline BonnerH-Index: 16
#2Julie Kerr-ConteH-Index: 40
Last. François PattouH-Index: 63
view all 15 authors...
The recently approved drug dapagliflozin is now shown to increase glucagon secretion by acting on pancreatic alpha cells, which has implications for the potency of its antidiabetic effects
255 CitationsSource
#1Kasper Aaboe (UCPH: University of Copenhagen)H-Index: 8
#2S. Akram (UCPH: University of Copenhagen)H-Index: 1
Last. Thure Krarup (UCPH: University of Copenhagen)H-Index: 42
view all 6 authors...
Aims To examine whether 12 weeks of treatment with a dipeptidyl peptidase-4 (DPP-4) inhibitor, sitagliptin, influences the insulin secretion induced by glucose, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) during a hyperglycaemic clamp in patients with type 2 diabetes (T2DM). Methods A randomized, double-blind, placebo-controlled study was conducted over 12 weeks, during which 25 patients with T2DM completed treatment with either sitagliptin (100 mg once...
19 CitationsSource
Inflammation is now appreciated to have an important role in the pathogenesis of type 2 diabetes and associated complications. Donath describes the underlying mechanisms and discusses the rationale for the use of anti-inflammatory agents — such as those that have been developed for rheumatoid arthritis and other diseases driven by inflammatory processes — in patients with diabetes.
332 CitationsSource
#1Sergio GhioneH-Index: 114
#2Elza MuscelliH-Index: 27
Last. Hans-Juergen WoerleH-Index: 61
view all 8 authors...
Background. Sodium-glucose cotransporter 2 (SGLT2) inhibitors lower glycemia by enhancing urinary glucose excretion. The physiologic response to pharmacologically induced acute or chronic glycosuria has not been investigated in human diabetes. Methods. We evaluated 66 patients with type 2 diabetes (62 ± 7 years, BMI = 31.6 ± 4.6 kg/m2, HbA1c = 55 ± 8 mmol/mol, mean ± SD) at baseline, after a single dose, and following 4-week treatment with empagliflozin (25 mg). At each time point, patients rece...
403 CitationsSource
#1Rozita H. Shirazi (University of Gothenburg)H-Index: 6
#2Vilborg Palsdottir (University of Gothenburg)H-Index: 9
Last. Karolina P. Skibicka (University of Gothenburg)H-Index: 30
view all 12 authors...
Glucagon-like peptide 1 (GLP-1), produced in the intestine and the brain, can stimulate insulin secretion from the pancreas and alleviate type 2 diabetes. The cytokine interleukin-6 (IL-6) may enhance insulin secretion from β-cells by stimulating peripheral GLP-1 production. GLP-1 and its analogs also reduce food intake and body weight, clinically beneficial actions that are likely exerted at the level of the CNS, but otherwise are poorly understood. The cytokines IL-6 and interleukin 1β (IL-1β)...
83 CitationsSource
#1Marc Y. DonathH-Index: 60
#2Elise DalmasH-Index: 8
Last. Marianne Böni-SchnetzlerH-Index: 18
view all 4 authors...
The role of the immune system is to restore functionality in response to stress. Increasing evidence shows that this function is not limited to insults by infection or injury and plays a role in response to overnutrition. Initially, this metabolic activation of the immune system is a physiological response, but it may become deleterious with time. Therefore, therapeutic interventions should aim at modulating the immune system rather than simply damping it. In this article, we describe the physio...
156 CitationsSource
#1Elisa Fernández-Millán (Complutense University of Madrid)H-Index: 10
#2J. de Toro-Martín (Complutense University of Madrid)H-Index: 2
Last. Carmen Álvarez (Complutense University of Madrid)H-Index: 17
view all 5 authors...
Aims/hypothesis Plasma glucagon concentrations rise sharply during the early postnatal period. This condition is associated with increased alpha cell mass. However, the trophic factors that regulate alpha cell turnover during the perinatal period have not been studied. Macrophage infiltrations are present in the neonatal pancreas, and this cell type releases cytokines such as IL-6. Alpha cells have been identified as a primary target of IL-6 actions. We therefore investigated the physiological r...
9 CitationsSource
Cited By30
#1Yanming Wang (XMU: Xinjiang Medical University)H-Index: 1
#2Dinareer Dilidaxi (XMU: Xinjiang Medical University)
Last. Xin-Hua Nabi (XMU: Xinjiang Medical University)H-Index: 2
view all 6 authors...
Abstract Backgroud/Aim Previous studies have found that probiotic fermented camel milk has anti-diabetic effect by inducing (glucagon-like peptide-1) GLP-1 secretion. Probiotics are valuable in prevention and treatment of diabetes. As a result, our team islolated 14 probiotics from fermented camel milk. These probiotics have beneficial characteristics, but the possible anti-diabetic mechanisms remains unclear. The present study aimed to explore the possoble anti-diabetic mechanisms of 14 probiot...
#1Rabeet Khan (Imperial College London)
#2Alejandra Tomas (Imperial College London)H-Index: 16
Last. Guy A. Rutter (Imperial College London)H-Index: 72
view all 3 authors...
Abstract Glucose-dependent insulinotropic polypeptide (GIP) is a gut-derived incretin that, in common with glucagon-like peptide-1 (GLP-1), has both insulin releasing and extra-pancreatic glucoregulatory actions. GIP is released in response to glucose or fat absorption and acts on the GIP receptor (GIPR) to potentiate insulin release from pancreatic beta cells. GIP has also been shown to promote beta cell survival and stimulate the release of GLP-1 from islet alpha cells. There is now evidence t...
#1Youngmi Song (SKKU: Sungkyunkwan University)H-Index: 1
#2Jacqueline A. Koehler (Lunenfeld-Tanenbaum Research Institute)H-Index: 4
Last. Daniel J. Drucker (Lunenfeld-Tanenbaum Research Institute)H-Index: 106
view all 6 authors...
Summary The importance of pancreatic versus intestinal-derived GLP-1 for glucose homeostasis is controversial. We detected active GLP-1 in the mouse and human pancreas, albeit at extremely low levels relative to glucagon. Accordingly, to elucidate the metabolic importance of intestinal proglucagon-derived peptides (PGDPs), we generated mice with reduction of Gcg expression within the distal (GcgDistalGut−/−) or entire (GcgGut−/−) gut. Substantial reduction of gut Gcg expression markedly reduced ...
2 CitationsSource
#1Chiara Saponaro (French Institute of Health and Medical Research)H-Index: 1
#2Valery Gmyr (French Institute of Health and Medical Research)H-Index: 24
Last. Caroline Bonner (French Institute of Health and Medical Research)H-Index: 16
view all 17 authors...
Summary The newest classes of anti-diabetic agents include sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor (GLP1R) agonists. The SGLT2 inhibitor dapagliflozin reduces glucotoxicity by glycosuria but elevates glucagon secretion. The GLP1R agonist liraglutide inhibits glucagon; therefore, we hypothesize that the cotreatment of dapagliflozin with liraglutide could reduce hyperglucagonemia and hyperglycemia. Here we use five complementary models: human islet cu...
#1Alejandra Tomas (Imperial College London)H-Index: 16
#2Ben Jones (Imperial College London)H-Index: 8
Last. Colin A. Leech (State University of New York Upstate Medical University)H-Index: 28
view all 3 authors...
Abstract Harnessing the translational potential of the GLP-1/GLP-1R system in pancreatic beta cells has led to the development of established GLP-1R-based therapies for the long-term preservation of beta cell function. In this review, we discuss recent advances in the current research on the GLP-1/GLP-1R system in beta cells, including the regulation of signaling by endocytic trafficking as well as the application of concepts such as signal bias, allosteric modulation, dual agonism, polymorphic ...
#1Lap Hang Tse (HKUST: Hong Kong University of Science and Technology)
#2Yung Hou Wong (HKUST: Hong Kong University of Science and Technology)H-Index: 38
G protein-coupled receptors (GPCRs) constitute the largest superfamily of integral membrane protein receptors. As signal detectors, the several hundred known GPCRs are responsible for sensing the plethora of endogenous ligands that are critical for the functioning of our endocrine system. Although GPCRs are typically considered as detectors for first messengers in classical signal transduction pathways, they seldom operate in isolation in complex biological systems. Intercellular communication b...
#1Louise Lang Lehrskov (UCPH: University of Copenhagen)H-Index: 3
#2Regitse Højgaard Christensen (UCPH: University of Copenhagen)H-Index: 4
Low-grade inflammation is recognized as an important factor in the development and progression of a multitude of diseases including type 2 diabetes mellitus and cardiovascular disease. The potential of using antibody-based therapies that neutralize key players of low-grade inflammation has gained scientific momentum as a novel therapeutic strategy in metabolic diseases. As interleukin-6 (IL-6) is traditionally considered a key pro-inflammatory factor, the potential of expanding the use of anti-I...
2 CitationsSource
#1Sujin Kang (Osaka University)H-Index: 15
#2Toshio TanakaH-Index: 49
Last. Tadamitsukishimoto (Osaka University)H-Index: 167
view all 4 authors...
Interleukin-6 (IL-6) is a pleiotropic cytokine with roles in immunity, tissue regeneration, and metabolism. Rapid production of IL-6 contributes to host defense during infection and tissue injury, but excessive synthesis of IL-6 and dysregulation of IL-6 receptor signaling is involved in disease pathology. Therapeutic agents targeting the IL-6 axis are effective in rheumatoid arthritis, and applications are being extended to other settings of acute and chronic inflammation. Recent studies reveal...
5 CitationsSource
#1Wei He (University of Bremen)H-Index: 2
#2Osmond Rebello (University of Bremen)H-Index: 1
Last. Kathrin Maedler (University of Bremen)H-Index: 35
view all 7 authors...
Abstract Type 2 Diabetes (T2D) is strongly associated with obesity and inflammation. Toll-like receptor-4 (TLR-4) is the major pro-inflammatory pathway with its ligands and downstream products increased systemically in T2D and in at-risk individuals. Detailed mechanisms of the complex proinflammatory response in pancreatic islets remain unknown. In isolated human islets LPS induced IL-1β, IL-6, IL-8 and TNF production in a TLR4-dependent manner and severely impaired β-cell survival and function....
2 CitationsSource
#1Pan Liu (SDU: Shandong University)H-Index: 2
#2Jia Song (SDU: Shandong University)H-Index: 1
Last. Li Chen (SDU: Shandong University)H-Index: 10
view all 9 authors...
Purpose Proglucagon is expressed in both pancreatic alpha cells and intestinal epithelial L cells and is cleaved into glucagon and glucagon-like peptide-1 (GLP-1) by different prohormone convertases (PCs). Recent studies have shown that α-cells can also secrete GLP-1, which may improve islet function. However, little is known about the factors influencing GLP-1 secretion by α cells. In this study, we investigated whether insulin promotes GLP-1 secretion by α cells, as well as the mechanisms unde...
2 CitationsSource